x
Breaking News
0

Adamis Pharma (ADMP)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Adamis Pharmaceuticals Corporation's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
4.46 +0.06    +1.46%
19:29:21 GMT - Real-time CFD Data. Currency in USD ( Disclaimer )
Type: Equity
Market: United States
ISIN: US00547W2089 
CUSIP: 00547W208
  • Volume: 312,138
  • Bid/Ask: 4.45 / 4.50
  • Day's Range: 4.30 - 4.55
Start Trading
Adamis Pharmaceuticals Corporation 4.46 +0.06 +1.46%

ADMP Overview

 
Information about the Adamis Pharma Stock. You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others.
Loading
Last Update:
  • 1 Day
  • 1 Week
  • 1 Month
  • 3 Months
  • 6 Months
  • 1 Year
  • 5 years
  • Max
Prev. Close4.4
Day's Range4.3 - 4.55
Revenue12.71M
Open4.35
52 wk Range2.55 - 6.45
EPS - 0.7
Volume312,138
Market Cap146.9M
Dividend (Yield)0 (N/A)
Average Vol. (3m)593,161
P/E RatioN/A
Beta0.29
1-Year Change44.26%
Shares Outstanding33,386,982
Next Earnings DateN/A
What is your sentiment on Adamis Pharmaceuticals Corporation?
or
Vote to see community's results!

Technical Summary

Type 5 mins 15 mins Hourly Daily Monthly
Moving Averages Strong Sell Strong Sell Sell Sell Sell
Technical Indicators Strong Sell Sell Sell Neutral BUY
Summary Strong Sell Strong Sell Sell Neutral Neutral

Candlestick Patterns

 

Filter Table By:

Candle Sticks Characteristics:

Time Frame
Type
Pattern Indication
Reliability
Pattern Timeframe Reliability Candles Ago Candle Time
Emerging Patterns
Three Outside Down 15 Current
Completed Patterns
Engulfing Bearish 1M 1 Nov 17
Abandoned Baby Bullish 5H 1 Dec 15, 2017 05:00AM
Engulfing Bearish 15 1 Dec 15, 2017 01:45PM

Adamis Pharma News & Analysis

Adamis Pharma Quotes

Exchange Last Bid Ask Volume Change % Currency Time
  NASDAQ 4.46 4.45 4.50 312,138 +1.46% USD 19:29:21  
  Stuttgart 3.673 3.637 3.891 0 +3.70% EUR 16:55:00  

Trending Stocks

Create Alert
Add to Portfolio
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

  Name Last High Low Chg. Chg. % Vol. Time
  Tesla 339.44 342.93 335.80 +1.55 +0.46% 4.59M 19:30:20  
  LongFin A 24.35 26.43 7.86 +18.95 +350.93% 12.72M 19:30:37  
  Apple 173.48 173.68 172.46 +1.26 +0.73% 23.03M 19:30:30  
  Riot Blockchain 28.9046 29.4900 26.7900 +3.9246 +15.71% 10.54M 19:29:58  
  Amazon.com 1,178.96 1,182.75 1,169.33 +4.70 +0.40% 2.84M 19:30:25  
  NVIDIA 190.52 192.38 185.67 +4.05 +2.17% 11.22M 19:30:26  
  Digital Power 4.801 5.070 4.680 -0.199 -3.98% 6.86M 19:29:55  
  Teva ADR 18.42 18.70 17.50 +1.12 +6.47% 52.68M 19:30:38  
  Alibaba 172.74 173.04 170.00 +0.99 +0.58% 20.78M 19:30:31  
  Micron 42.45 42.56 41.88 +0.20 +0.49% 31.93M 19:30:37  

Adamis Pharma Company Profile

IndustryBiotechnology & Drugs
SectorHealthcare
Employees

14

Equity Type

ORD

Adamis Pharmaceuticals Corporation is a pharmaceutical company. The Company is engaged in the development of its specialty pharmaceutical products. The Company is developing various products in the allergy and respiratory markets, including a dry powder inhaler technology that it acquired from 3M Company (3M). The Company's product portfolio includes specialty pharmaceutical products, such as Epinephrine pre-filled syringe (PFS), APC-5000 dry powder inhaler (DPI), APC-1000 and APC-2000, and biotechnology products, such as TeloB-VAX (vaccine), APC-100, APC-200 and APC-300. The Company's lead product candidate, the Epinephrine Injection USP 1:1000 0.3 milligram Pre-filled Single Dose Syringe, or the Epinephrine PFS, is a pre-filled syringe designed to deliver a premeasured 0.3 milligrams dose of epinephrine for the treatment of anaphylaxis. The Company also has licensed vaccine technology called somatic transgene immunization (STI) technology.

Read More

Start Trading With Top Industry Brokers

Brokers Regulation Minimum Deposit
U.S. Commodity Futures Trading Commission (United States) $250 Start Trading
National Futures Association (United States), U.S. Commodity Futures Trading Commission (United States), The Financial Conduct Authority (United Kingdom), Australian Securities and Investments Commission (Australia), Financial Industry Regulatory Authority (United States), Investment Industry Regulatory Organization of Canada (Canada), Securities and Exchange Board of India (India), Securities and Exchange Commission (United States), The Securities and Futures Commission (Hong Kong), Securities Investor Protection Corporation (United States) $10000 Start Trading
U.S. Commodity Futures Trading Commission (United States) Start Trading

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

 
Are you sure you want to delete this chart?
 
Write your thoughts about Adamis Pharma
 
Replace the attached chart with a new chart ?
Post
Post also to:
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
 
Replace the attached chart with a new chart ?
Post 1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email